Federal regulations require pharmaceutical distributors to abide by specific guidelines governing distribution of pharmaceuticals. A-Plus Corporation, a licensed pharmaceutical distributor located in California, sells brand-name drugs, generic drugs and controlled drugs to U.S. friendly countries around the globe.
Discover why many clients and customers choose A-Plus Corporation as the ideal choice for importing U.S. pharmaceutical products.
The Drug Distribution System In The United States
The Consumer Healthcare Products Association (CHPA) explains that pharmaceutical distribution in the U.S. is a two-class system, including prescription and non-prescription or over-the-counter medicines. Strict guidelines dictate that all pharmaceutical distributors obtain licensing, that they continue to maintain active licensing and follow all laws and standards set for distribution of both prescription and OTC drugs. The U.S. Food and Drug Administration (FDA) regulates uniformity in these guidelines, indicating that it does so on the federal level, which prevents overlapping of regulations at the state level.
Such uniformity also allows for A-Plus Corporation to stay up-to-date and follow all legal guidelines around the United States as well as around the globe. As a dedicated pharma export source, A-Plus Corporation is licensed by both the California State Board of Pharmacy and the DEA. The company also boasts more than 20 years service as a pharmaceutical distributor.
Choosing A-Plus Corporation As Your Only Pharmaceutical Distributor
The World Health Organization (WHO) points out that informal controls on pharmaceutical distribution are not sufficient. WHO states, “The most important factor in the effectiveness of pharmaceutical laws and regulations is the extent to which legislative framework is in tune with national policy and existing situation in the pharmaceutical sector.”
With the exceptional legal experience at A-Plus Corporation, you never have to feel concern over any shipment issue. Note that although some prescription drugs have recently become over-the-counter medications, this change does not mean there are more lax regulations on these medications.
Additionally, decisions to place some drugs, such as those containing pseudoephedrine, behind the pharmacy counter do not affect A-Plus Corporation. Each pharmacy incurs responsibility for proper placement of all pharmaceuticals. The company is not an online pharmacy, instead focusing solely on pharmaceutical distribution to professional healthcare locations worldwide, including pharmacies, clinics and medical facilities. Utilizing an industry-leading asset and supply management technology, A-Plus Corporation employs the most convenient and cost-effective solution for each customer’s needs.
All A-Plus products meet FDA approval, meaning that clients do not have to worry about lack of transparency or multiple regulations across various U.S. friendly countries. Clients receive the highest level of service and products with each shipment that meets all laws, regulations and guidelines of the United States and U.S. friendly countries.
Source
https://www.chpa.org/FAQDrugDistribution.aspx
https://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/Over-the-CounterDrugs/default.htm
http://apps.who.int/medicinedocs/documents/s19583en/s19583en.pdf
